Judith M. Zilberman
Grupo México
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Judith M. Zilberman.
International Journal of Hypertension | 2012
Augusto Vicario; Mildren Del Sueldo; Ruth Fernández; Julio Enrique Enders; Judith M. Zilberman; Gustavo H. Cerezo
We conducted an epidemiological approach to identify the negative impact of the vascular risk factors (such as hypertension, diabetes and hypercholesterolemia) over cognition. The interesting aspect of this study was that the survey was conducted in all age groups through a voluntary call (n = 1365; ≥18 years old, both sexes; age 49 ± 15 y, female 75.7%). Thus, we demonstrated that the use of a Minimum Cognitive Examination (MCE), a brief, simple, and easy managed neuropsychological evaluation, detected a greater number of people with cognitive decline surpassing to the Minimal Mental Statement Examination alone (14.5% of the participants showed MMSE ≤24, 34,6% showed dys-executive function, and 45,8% memory impairment. Out of the 4 studied RF, the only one that was not related to cognitive impairment was dyslipemia. Finally, we noted the importance of cognitive state early detection in all age groups, even in the youngest group. Acting in the middle of the life stages, we can prevent or delay the onset of a disease in adults, nowadays incurable: dementia.
Vascular Health and Risk Management | 2011
Augusto Vicario; Mildren Del Sueldo; Judith M. Zilberman; Gustavo H. Cerezo
Background: Several studies have examined the links between hypertension, vascular damage, and cognitive impairment. The functions most commonly involved seem to be those associated with memory and executive function. Aims: 1) to report the cognitive evolution in a cohort of hypertensive patients, 2) to identify the affected domains, and 3) to correlate the results obtained with blood pressure measurements. Materials and Methods: Observational 6-year follow-up cohort study including both males and females aged ≥65 and ≤80 years, and hypertensive patients under treatment. Patients with a history of any of the following conditions were excluded: stroke, transient ischemic attack, diabetes mellitus, atrial fibrillation, cardiac surgery, dementia, or depression. Four neurocognitive evaluations were performed (at baseline and every 2 years). The tests used evaluated memory and executive function domain. Blood pressure was measured on every cognitive evaluation. Results: Sixty patients were followed for 76.4 ± 2.8 months. The average age at baseline was 72.5 ± 4.2 and 77.9 ± 4.6 at 6 years (65% were women). Two patients were lost to follow up (3.3%) and 8 patients died (13.3%).The density incidence for dementia was 0.6% patients per year (pt/y) (n = 3) and for depression was 1.6% pt/y (n = 12). No changes were observed in either memory impairment or the Mini Mental State Examination (MMSE) results (p = ns) during follow-up. A progressive impairment of the executive function was shown regardless of the blood pressure measurements. Conclusion: 1) the incidence of dementia doubled to general population, 2) the initial memory impairment did not change during the evaluation period, 3) cognitive impairment worsened in the areas related to executive function (prefrontal cortex) regardless of the adequacy of anti-hypertensive treatment and blood pressure values.
Neurología Argentina | 2010
Augusto Vicario; Nora Vainstein; Judith M. Zilberman; Mildren Del Sueldo; Gustavo H. Cerezo
Resumen Introduccion La hipertension arterial, el mas prevalente y menos controlado de los factores de riesgo vascular, afecta a todas las arterias y entre ellas a las cerebrales. Este dano, subclinico por largos periodos de tiempo, causa isquemia subcortical e “infartos silentes”, comprometiendo el funcionamiento de varios dominios cognitivos y deviniendo en algunos casos en compromiso irreversible de las funciones intelectuales superiores. Objetivo Aunque la causalidad entre la enfermedad vascular y la patologia cognitiva fue definida, esta revision pretende exponer nuestra experiencia y actualizar el estado del conocimiento sobre el tema. Desarrollo Los pacientes con dano vascular del cerebro y deterioro cognitivo incrementan cinco veces el riesgo de desarrollar sindromes demenciales (demencia tipo vascular o demencia tipo Alzheimer), y ademas son proclives a presentar trastornos animicos (depresion). El compromiso vascular en la enfermedad de Alzheimer impacta en forma negativa sobre el pronostico, acelerando su evolucion. Conclusion El establecimiento de patrones de conducta interdisciplinarios que operen con una actitud preventiva efectiva logra tanto el control de la hipertension arterial y otros factores de riesgo como la deteccion del compromiso cognitivo.
Rev. argent. cardiol | 2004
Alberto S. Villamil; Claudia Rodriguez; M. Badia; Laura S. López; Judith M. Zilberman; Rodolfo L. Salinas; María A. Gregoretti; Susana I. Blanco; Luis A. Vidal
Argentine Journal of Cardiology | 2012
Judith M. Zilberman; Luis Cicco; Eliana Woronko; Nora Vainstein; Vanina Sczcygiel; Roger Ghigi; Sandra Grippo; Alberto S. Villamil
Revista Colombiana de Cardiología | 2018
Mildren Del Sueldo; Augusto Vicario; Gustavo H. Cerezo; Gonzalo Miranda; Judith M. Zilberman
International Journal of Women's Health | 2018
Mildren Del Sueldo; Nieves Martell-Claros; María Abad-Cardiel; Judith M. Zilberman; Raul Marchegiani; Cristina Fernández-Pérez
Revista Argentina de Cardiología | 2012
Judith M. Zilberman; Luis Cicco; Eliana Woronko; Nora Vainstein; Vanina Szczygiel; Roger Ghigi; Sandra Grippo; Alberto S. Villamil
Rev. Hosp. Ital. B. Aires (2004) | 2012
Jessica Barochiner; José Alfie; Lucas S. Aparicio; Margarita S. Morales; Paula E. Cuffaro; Marcelo A. Rada; Carlos R. Galarza; Roberto Ingaramo; Jorge Resk; Alberto S. Villamil; Carlos Borrego; Judith M. Zilberman; Gabriel Waisman
Archive | 2012
Judith M. Zilberman; Luis Cicco; Eliana Woronko; Nora Vainstein; Vanina Szczygiel; Roger Ghigi; Sandra Grippo; Alberto S. Villamil